Understanding language development in infants at risk for autism and ADHD
Examining transdiagnostic mechanisms of language development in infants at elevated likelihood for autism and ADHD
This study is looking at how babies who might be at risk for autism and ADHD learn to talk, using a fun eye-tracking game to see how they connect words to their meanings and the world, so we can better understand their language development.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10997219 on NIH RePORTER |
What this research studies
This research investigates how language development occurs in infants who are at a higher risk for autism and ADHD. By examining a group of infants over time, the study aims to identify common mechanisms that may lead to language delays in these populations. The research utilizes a novel eye-tracking task to observe how infants connect words with their meanings and the world around them. This approach allows for a deeper understanding of the developmental processes involved in language acquisition, particularly in those who may face challenges.
Who could benefit from this research
Good fit: Ideal candidates for participation are infants aged 0-36 months who have a familial likelihood of developing autism or ADHD.
Not a fit: Infants who do not have a familial history of autism or ADHD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early interventions for infants at risk for autism and ADHD, enhancing their language development.
How similar studies have performed: Previous research has shown promise in understanding language development in similar populations, but this study's transdiagnostic approach is relatively novel.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Piergies, Antonia — University of California at Davis
- Study coordinator: Piergies, Antonia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.